The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab and tremelimumab plus local tumor ablation (RFA or stereotactic radiotherapy) in patients with metastatic colorectal cancer with unresectable liver metastases: Results of the EORTC-1560-GITCG (ILOC) phase II study.
 
Jenny F. Seligmann
Honoraria - Merck Serono; Pierre Fabre; SERVIER
Consulting or Advisory Role - Pierre Fabre; Zentalis
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex
 
Thibaud Kossler
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; MSD; Pierre Fabre
Travel, Accommodations, Expenses - Ipsen; Lilly; Pierre Fabre; Sanofi
 
Murielle Mauer
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Roche (Inst)
 
Serge Evrard
No Relationships to Disclose
 
Elske C. Gootjes
No Relationships to Disclose
 
Jacob Freedman
No Relationships to Disclose
 
Matthias Guckenberger
Research Funding - ViewRay (Inst)
 
Anne-Sophie Govaerts
No Relationships to Disclose
 
Anne Giraut
No Relationships to Disclose
 
Jens Ricke
No Relationships to Disclose
 
Gunnar Folprecht
Honoraria - Bristol-Myers Squibb; Falk Foundation; Merck KGaA; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exact Sciences; Incyte; Merck KGaA; Merck Sharp & Dohme; Pierre Fabre; Roche/Genentech; SERVIER
Research Funding - Merck KGaA
 
Dirk Arnold
Employment - Asklepios Kliniken
Honoraria - Amgen; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; Ipsen; Merck Serono; Merck Sharp and Dome; Pierre Fabre; Roche/Genentech; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; Biocompatibles; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Terumo
Research Funding - Oncolytics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Boston Scientific
(OPTIONAL) Uncompensated Relationships - ESMO; ESMO Open; European Organisation for Research and Treatment of Cancer (EORTC); German Cancer Society; German Society for Hematology and Medical Oncology
 
Ramesh Vishwakarma
Research Funding - AstraZeneca
 
Michel Ducreux
Employment - Sandoz (I)
Honoraria - Bayer; Pierre Fabre; Roche/Genentech; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Basilea; Bayer; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; HalioDx; Ipsen; Lilly; Merck Serono; MSD; Novartis; Pierre Fabre; Rafael Pharmaceuticals; Roche; Servier; Sotio; Zymeworks
Speakers' Bureau - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; HalioDx; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; SERVIER
Research Funding - Keocyt (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Pierre Fabre; Roche; SERVIER
 
Theo JM Ruers
No Relationships to Disclose